ACVC Premium Access

hs-troponin should be used in unselected patients with suspected ACS. PRO.

Presentation

About the speaker

Professor Bertil Lindahl

Uppsala University, Uppsala (Sweden)
14 presentations
1 follower

5 more presentations in this session

hs-troponin should be used in unselected patients with suspected ACS. CONTRA.

Speaker: Professor M. Moeckel (Berlin, DE)

Thumbnail

hs-troponin should be used in unselected patients with suspected ACS. Discussion.

Thumbnail

We need to add a risk score to hs-troponin - PRO.

Speaker: Doctor M. Tubaro (Rome, IT)

Thumbnail

We need to add a risk score to hs-troponin - CONTRA.

Speaker: Doctor J. Boeddinghaus (Basel, CH)

Thumbnail

We need to add a risk score to hs-troponin - Discussion.

Thumbnail

Access the full session

Controversies in diagnostic strategies for chest pain patients

Speakers: Professor B. Lindahl, Professor M. Moeckel, Doctor M. Tubaro, Doctor J. Boeddinghaus
Thumbnail

About the event

Image

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk